Idiopathic Intracranial Hypertension

Idiopathic intracranial hypertension (IIH) is where patients have increased intracranial pressure without an identifiable cause, typically manifesting in headache and other symptoms.

Pathophysiology


  • If you break down the name of the condition, IIH involves raised intracranial pressure with no identifiable cause (idiopathic).
  • The precise aetiology is still not known but several theories exist on the cause.
  • One example is a proposition of transverse venous sinus stenosis. The intracranial venous sinuses are responsible for CSF drainage, so a proposed mechanism is stenosis of the transverse sinus ultimately results in reduced CSF reabsorption and thus higher pressures.
  • Other theories do exist such as abnormalities in vitamin A metabolism or the presence of microthrombi in cerebral veins.

Risk Factors


  • Female sex and obesity: IIH most commonly affects young, obese women.
  • Sleep apnoea
  • Polycystic ovarian syndrome
  • Association with certain drugs including isotretinoin (Roaccutane), tetraycyclines and nitrofurantoin

Clinical Features


  • Headache:
    • Usually bilateral
    • May be worsened by coughing/sneezing/straining.
    • Can be described as being worse in the mornings
    • Can be worsened by lying down/bending forward and relieved by standing up
  • Pulsatile tinnitus
  • Visual disturbances
    • Transient vision loss, particularly when bending down
    • Bilateral papilledema
    • Diplopia
    • Decreased visual acuity
    • Painful eye movements
    • 6th nerve palsy
    • Peripheral vision loss
  • Pain in the back or neck

Investigations


Based on the clinical history, it is important to rule out any other causes of raised intracranial pressure prior to making a diagnosis of IIH.

Bedside

  • History & Examination (Particularly cranial nerves, upper limb neurological and lower limb neurological)
  • Fundoscopy: Visualise papilledema
  • Lumbar puncture: Typically shows a raised opening pressure (>25cm3) but is otherwise normal. Lumbar punctures may also be therapeutic.

 

Imaging

  • CT or MRI: No obvious lesions should be identified on CT/MRI i.e. by definition; an intracranial mass cannot be responsible for IIH as IIH is characterised by being idiopathic. The empty sella sign may be visualised, which is a flattened pituitary gland, occurring as a result of increased pressure
  • CT or MRI venogram: To exclude venous sinus thrombosis

Special Tests

  • Visual field testing (Perimetry)

Management


Conservative

  • Advise weight reduction – may be able to involve dietetics to facilitate this

Medical

  • Acetazolamide: This is a carbonic anhydrase inhibitor. It is an effective drug used to lower intracranial pressure as it reduces CSF production. Can be poorly tolerated due to side effects:
    • Paraesthesia, particularly in the extremities
    • Tinnitus
    • Lethargy
    • Altered taste
  • Topiramate: Used as an alternative to acetazolamide as it has weak carbonic anhydrase properties.

 

Surgical

  • Lumbo-peritoneal or ventriculo-peritoneal shunting: Shunting CSF into the abdomen either from the lumbar spine or from the ventricle
  • Optic nerve sheath fenestration: Creating opening in the sheath of the optic nerve to help relieve pressure from the nerve and protect against visual field loss.

References


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544160/#:~:text=Go%20to%3A-,PATHOPHYSIOLOGY%20OF%20IIH,and%20increased%20cerebral%20venous%20pressure.

https://jnnp.bmj.com/content/89/10/1088

https://www.touchophthalmology.com/neuro-ophthalmology/journal-articles/optic-nerve-sheath-fenestration-indications-and-techniques/

https://www.pacificneuroscienceinstitute.org/hydrocephalus/treatment/shunt-procedures/lumboperitoneal-shunt/

https://www.mskcc.org/cancer-care/patient-education/about-your-ventriculoperitoneal-vp-shunt-surgery